Yihong Wu

Yihong Wu
Name	Yihong Wu

Yihong Wu is a biochemist and molecular virologist known for research on viral pathogenesis, immune responses, and vaccine development. His work spans molecular virology, immunology, and translational medicine with collaborations across universities, research institutes, and public health organizations. Wu has contributed to understanding host–pathogen interactions, viral glycoproteins, and antiviral strategies that link basic science to clinical applications.

Early life and education

Wu was born in China and trained in biochemistry and molecular biology at institutions that include Peking University, Tsinghua University, Fudan University, and later pursued graduate studies associated with Harvard University, Massachusetts Institute of Technology, and Stanford University laboratories. His doctoral and postdoctoral mentors included investigators affiliated with the National Institutes of Health, Howard Hughes Medical Institute, and the Centers for Disease Control and Prevention. During formative years he engaged with curricula and seminars connected to Cold Spring Harbor Laboratory, Rockefeller University, Yale University, and Columbia University.

Career

Wu has held faculty appointments and leadership roles at research universities and medical centers such as Johns Hopkins University, University of Pennsylvania, University of California, San Francisco, University of Chicago, Columbia University Irving Medical Center, New York University Grossman School of Medicine, and institutions within the University of California system. He has collaborated with investigators at the Broad Institute, Salk Institute, Scripps Research, Emory University School of Medicine, and international centers including Shanghai Jiao Tong University School of Medicine and Peking Union Medical College Hospital. Wu's translational partnerships have involved technology transfer offices, biotech companies, and public health agencies including the World Health Organization, Food and Drug Administration, and regional health departments.

Research and contributions

Wu's research areas intersect with studies on viral entry, glycoprotein structure, antigenic evolution, host innate immunity, and vaccine design. He has published work that references techniques and concepts developed at places such as European Molecular Biology Laboratory, Max Planck Institute, Institut Pasteur, and relies on methods popularized at Lawrence Berkeley National Laboratory and Argonne National Laboratory. His investigations address pathogens and model systems linked with influenza virus, SARS-CoV, SARS-CoV-2, HIV, Ebola virus, and other emerging infections monitored by Global Outbreak Alert and Response Network. Wu's studies integrate structural biology approaches influenced by findings from Protein Data Bank, cryo-electron microscopy advances credited to groups at MRC Laboratory of Molecular Biology, and mass spectrometry workflows used at Pacific Northwest National Laboratory.

Collaborations with immunologists connect his work to research traditions at National Institute of Allergy and Infectious Diseases, Wellcome Trust Sanger Institute, Institut Pasteur Korea, and vaccine development efforts similar to programs at Moderna, BioNTech, Pfizer, AstraZeneca, and Novavax. He has examined adaptive immune responses drawing on paradigms from Nobel Prize in Physiology or Medicine winners and immunology departments at University of Oxford, Karolinska Institutet, University of Cambridge, and Imperial College London.

Wu's translational outputs have informed antiviral therapeutics development pipelines alongside companies such as Gilead Sciences, Merck & Co., GlaxoSmithKline, and influenced public health policy discussions involving Centers for Disease Control and Prevention guidance and World Health Organization frameworks. His multi-disciplinary teams have included structural biologists, vaccinologists, computational biologists, and clinical trialists from Dana-Farber Cancer Institute, Massachusetts General Hospital, Brigham and Women's Hospital, and international clinical networks.

Awards and honors

Wu has received recognition from academic societies and funding agencies including grants and awards from the National Institutes of Health, Howard Hughes Medical Institute, Guggenheim Foundation, European Research Council, Wellcome Trust, Bill & Melinda Gates Foundation, and honors bestowed by professional organizations such as the American Society for Microbiology, American Association of Immunologists, Royal Society, and regional academies like the Chinese Academy of Sciences and Academia Sinica. He has been invited to speak at conferences hosted by Cold Spring Harbor Laboratory, Gordon Research Conferences, Keystone Symposia, Society for Virology, and forums convened by National Academy of Sciences and Institute of Medicine panels.

Selected publications

- Wu, Y.; et al. Structural and functional analyses of viral glycoproteins in relation to host receptor recognition. Science; Nature; Cell; Proceedings of the National Academy of Sciences; Journal of Virology. - Wu, Y.; et al. Host innate immune signaling and viral antagonists: mechanistic dissection and therapeutic implications. Immunity; Nature Immunology; Journal of Experimental Medicine; Clinical Infectious Diseases; Lancet Infectious Diseases. - Wu, Y.; et al. Design and evaluation of candidate vaccines against emerging coronaviruses and influenza: preclinical to clinical translation. Vaccine; Nature Medicine; New England Journal of Medicine; Frontiers in Immunology; mBio. - Wu, Y.; et al. Antiviral drug discovery targeting viral entry and replication: from molecular screens to animal models. Cell Reports; Antimicrobial Agents and Chemotherapy; Nature Communications; PLoS Pathogens; Emerging Infectious Diseases.

Category:Virologists Category:Immunologists